Impact of net charge, targeting ligand amount and mRNA modification on the uptake, intracellular routing and the transfection efficiency of mRNA lipopolyplexes in dendritic cells.


Journal

International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127

Informations de publication

Date de publication:
25 Nov 2023
Historique:
received: 05 06 2023
revised: 08 10 2023
accepted: 17 10 2023
medline: 20 11 2023
pubmed: 21 10 2023
entrez: 20 10 2023
Statut: ppublish

Résumé

Targeting mRNA formulations to achieve cell specificity is one of the challenges that must be tackled to mettle their therapeutic potential. Here, lipopolyplexes (LPR) bearing tri-mannose-lipid (TM) are used to target mannose receptor on dendritic cells. We investigated the impact of the net charge and percentage of TM units on the binding, uptake, transfection efficiency (TE) and RNA sensors activation. Binding and uptake capacities of naked and targeted LPR increase with the percent of cationic lipid, but the latter are 2-fold more up taken by the cells. Cationic LPR bearing 5 % and 10 % TM were localized in acidic compartments in contrast to naked LPR and 2.5 % TM-LPR. The drawback is the dramatic decrease of TE as the number of TM-units increases. Cationic LPR bearing 5 % and 10 % TM strongly induced NF-κB and PKR phosphorylation at 6 h. Conversely, mTOR is less activated in line with their low TE. Those side effects are overcome by using 5-methoxyuridine mRNA resulting in an improved TE due to non-phosphorylation of NF-κB and PKR and mTOR activation. Our results point out that targeting DC via mannose receptor triggers a higher uptake of cationic LPRs and fast routing to acidic compartments, and that efficient TE requires low number of TM units use or modified mRNA to escape RNA sensors activation to enhance the translation.

Identifiants

pubmed: 37863445
pii: S0378-5173(23)00952-3
doi: 10.1016/j.ijpharm.2023.123531
pii:
doi:

Substances chimiques

Ligands 0
RNA, Messenger 0
Mannose Receptor 0
NF-kappa B 0
Lipids 0
TOR Serine-Threonine Kinases EC 2.7.11.1
Liposomes 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

123531

Informations de copyright

Copyright © 2023. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Christophe Delehedde (C)

Centre de Biophysique Moléculaire, CNRS UPR4301, F-45071, Orléans cedex 02, France; Sanofi R&D, Integrated Drug Discovery, Chilly-Mazarin, France.

Ivan Ciganek (I)

Centre de Biophysique Moléculaire, CNRS UPR4301, F-45071, Orléans cedex 02, France.

Nathalie Rameix (N)

Sanofi R&D, Integrated Drug Discovery, Chilly-Mazarin, France.

Nabila Laroui (N)

Centre de Biophysique Moléculaire, CNRS UPR4301, F-45071, Orléans cedex 02, France.

Cristine Gonçalves (C)

Centre de Biophysique Moléculaire, CNRS UPR4301, F-45071, Orléans cedex 02, France.

Luc Even (L)

Sanofi R&D, Integrated Drug Discovery, Chilly-Mazarin, France.

Patrick Midoux (P)

Centre de Biophysique Moléculaire, CNRS UPR4301, F-45071, Orléans cedex 02, France.

Chantal Pichon (C)

Centre de Biophysique Moléculaire, CNRS UPR4301, F-45071, Orléans cedex 02, France; Inserm UMS 55 ART ARNm and University of Orléans, F-45100 Orléans; Institut Universitaire de France, 1 rue Descartes, F-75035 Paris, France. Electronic address: chantal.pichon@univ-orleans.fr.

Articles similaires

Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
T-Lymphocytes, Regulatory Lung Neoplasms Proto-Oncogene Proteins p21(ras) Animals Humans
Animals Humans Nickel Mice Immunotherapy
Humans Endoribonucleases RNA, Messenger RNA Caps Gene Expression Regulation

Classifications MeSH